• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高脂肪喂养诱导代谢相关脂肪性肝病(MAFLD)大鼠的线粒体质量控制改变。

Altered Mitochondrial Quality Control in Rats with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Induced by High-Fat Feeding.

机构信息

Department of Sciences and Technologies, University of Sannio, 82100 Benevento, Italy.

Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania "L. Vanvitelli", 81100 Caserta, Italy.

出版信息

Genes (Basel). 2022 Feb 8;13(2):315. doi: 10.3390/genes13020315.

DOI:10.3390/genes13020315
PMID:35205361
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8871726/
Abstract

Metabolic dysfunction-associated fatty liver disease (MAFLD) is defined as the presence of hepatic steatosis in addition to one of three metabolic conditions: overweight/obesity, type 2 diabetes mellitus, or metabolic dysregulation. Chronic exposure to excess dietary fatty acids may cause hepatic steatosis and metabolic disturbances. The alteration of the quality of mitochondria is one of the factors that could contribute to the metabolic dysregulation of MAFDL. This study was designed to determine, in a rodent model of MAFLD, the effects of a long-term high-fat diet (HFD) on some hepatic processes that characterize mitochondrial quality control, such as biogenesis, dynamics, and mitophagy. To mimic the human manifestation of MAFLD, the rats were exposed to both an HFD and a housing temperature within the rat thermoneutral zone (28-30 °C). After 14 weeks of the HFD, the rats showed significant fat deposition and liver steatosis. Concomitantly, some important factors related to the hepatic mitochondrial quality were markedly affected, such as increased mitochondrial reactive oxygen species (ROS) production and mitochondrial DNA (mtDNA) damage; reduced mitochondrial biogenesis, mtDNA copy numbers, mtDNA repair, and mitochondrial fusion. HFD-fed rats also showed an impaired mitophagy. Overall, the obtained data shed new light on the network of different processes contributing to the failure of mitochondrial quality control as a central event for mitochondrial dysregulation in MAFLD.

摘要

代谢相关脂肪性肝病(MAFLD)的定义为在存在肝脂肪变性的基础上合并以下三种代谢异常之一:超重/肥胖、2 型糖尿病或代谢紊乱。长期暴露于过量膳食脂肪酸可能导致肝脂肪变性和代谢紊乱。线粒体质量改变是导致 MAFLD 代谢紊乱的因素之一。本研究旨在确定 MAFLD 啮齿动物模型中,长期高脂饮食(HFD)对一些特征性的线粒体质量控制的肝脏过程的影响,如生物发生、动力学和自噬。为了模拟 MAFLD 的人类表现,将大鼠暴露于 HFD 和大鼠的热中性区(28-30°C)的环境温度下。在 HFD 喂养 14 周后,大鼠出现明显的脂肪沉积和肝脂肪变性。同时,一些与肝脏线粒体质量相关的重要因素明显受到影响,如增加的线粒体活性氧(ROS)产生和线粒体 DNA(mtDNA)损伤;线粒体生物发生、mtDNA 拷贝数、mtDNA 修复和线粒体融合减少。HFD 喂养的大鼠也表现出自噬受损。总之,这些数据为不同的过程网络提供了新的认识,这些过程共同导致线粒体质量控制的失败,这是 MAFLD 中线粒体功能紊乱的核心事件。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51b3/8871726/ee69bf5f6047/genes-13-00315-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51b3/8871726/e776fd6598a6/genes-13-00315-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51b3/8871726/a9ca076ed6b4/genes-13-00315-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51b3/8871726/8998dc942dfc/genes-13-00315-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51b3/8871726/de35e4df1043/genes-13-00315-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51b3/8871726/05b98cdedc33/genes-13-00315-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51b3/8871726/b52f9eda6ebe/genes-13-00315-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51b3/8871726/b09f18cc9fad/genes-13-00315-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51b3/8871726/1b0a51a94118/genes-13-00315-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51b3/8871726/ee69bf5f6047/genes-13-00315-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51b3/8871726/e776fd6598a6/genes-13-00315-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51b3/8871726/a9ca076ed6b4/genes-13-00315-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51b3/8871726/8998dc942dfc/genes-13-00315-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51b3/8871726/de35e4df1043/genes-13-00315-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51b3/8871726/05b98cdedc33/genes-13-00315-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51b3/8871726/b52f9eda6ebe/genes-13-00315-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51b3/8871726/b09f18cc9fad/genes-13-00315-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51b3/8871726/1b0a51a94118/genes-13-00315-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51b3/8871726/ee69bf5f6047/genes-13-00315-g009.jpg

相似文献

1
Altered Mitochondrial Quality Control in Rats with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Induced by High-Fat Feeding.高脂肪喂养诱导代谢相关脂肪性肝病(MAFLD)大鼠的线粒体质量控制改变。
Genes (Basel). 2022 Feb 8;13(2):315. doi: 10.3390/genes13020315.
2
Assessment of mitochondrial function in metabolic dysfunction-associated fatty liver disease using obese mouse models.使用肥胖小鼠模型评估代谢功能障碍相关脂肪性肝病中的线粒体功能。
Zool Res. 2020 Sep 18;41(5):539-551. doi: 10.24272/j.issn.2095-8137.2020.051.
3
recognition of bioactive substances of for protecting mitochondria against metabolic dysfunction-associated fatty liver disease.鉴定对线粒体的生物活性物质,以防止代谢功能障碍相关的非酒精性脂肪性肝病。
World J Gastroenterol. 2023 Jan 7;29(1):171-189. doi: 10.3748/wjg.v29.i1.171.
4
Jiuzhuan Huangjing Pills relieve mitochondrial dysfunction and attenuate high-fat diet-induced metabolic dysfunction-associated fatty liver disease.九转黄精丸缓解线粒体功能障碍并减轻高脂肪饮食诱导的代谢功能障碍相关脂肪性肝病。
Biomed Pharmacother. 2021 Oct;142:112092. doi: 10.1016/j.biopha.2021.112092. Epub 2021 Aug 27.
5
A Diet Induced Maladaptive Increase in Hepatic Mitochondrial DNA Precedes OXPHOS Defects and May Contribute to Non-Alcoholic Fatty Liver Disease.饮食诱导的肝线粒体 DNA 适应性增加先于 OXPHOS 缺陷,可能导致非酒精性脂肪性肝病。
Cells. 2019 Oct 8;8(10):1222. doi: 10.3390/cells8101222.
6
Effects of Pyrroloquinoline Quinone on Lipid Metabolism and Anti-Oxidative Capacity in a High-Fat-Diet Metabolic Dysfunction-Associated Fatty Liver Disease Chick Model.吡咯喹啉醌对高脂饮食代谢相关脂肪性肝病鸡模型脂代谢及抗氧化能力的影响。
Int J Mol Sci. 2021 Feb 1;22(3):1458. doi: 10.3390/ijms22031458.
7
High fat diet-induced liver steatosis promotes an increase in liver mitochondrial biogenesis in response to hypoxia.高脂饮食诱导的肝脂肪变性促进肝脏线粒体生物发生增加以应对缺氧。
J Cell Mol Med. 2011 Jun;15(6):1329-38. doi: 10.1111/j.1582-4934.2010.01128.x. Epub 2010 Jul 12.
8
identification of bioactive components of for adjusting mitochondria against metabolic dysfunction-associated fatty liver disease.用于调节线粒体以对抗代谢功能障碍相关脂肪性肝病的生物活性成分的鉴定。
Heliyon. 2024 Aug 3;10(16):e35645. doi: 10.1016/j.heliyon.2024.e35645. eCollection 2024 Aug 30.
9
A high-fat diet impairs mitochondrial biogenesis, mitochondrial dynamics, and the respiratory chain complex in rat myocardial tissues.高脂肪饮食可损害大鼠心肌组织中线粒体生物发生、线粒体动力学和呼吸链复合物。
J Cell Biochem. 2018 Nov;119(11):9602. doi: 10.1002/jcb.27068. Epub 2018 Sep 1.
10
Regulation of hepatic mitochondrial metabolism in response to a high fat diet: a longitudinal study in rats.高脂饮食对肝脏线粒体代谢的调控:大鼠的纵向研究。
J Physiol Biochem. 2012 Sep;68(3):335-44. doi: 10.1007/s13105-012-0145-3. Epub 2012 Jan 26.

引用本文的文献

1
Peripheral blood mitochondrial DNA copy number as a predictor of steatotic liver disease development: insights from epidemiological and experimental studies.外周血线粒体DNA拷贝数作为脂肪性肝病发生的预测指标:来自流行病学和实验研究的见解
Environ Health Prev Med. 2025;30:42. doi: 10.1265/ehpm.25-00025.
2
Loss of ovarian function prevents exercise-induced activation of hepatic mitophagic flux.卵巢功能丧失会阻止运动诱导的肝脏线粒体自噬通量的激活。
Am J Physiol Endocrinol Metab. 2025 Jun 1;328(6):E869-E884. doi: 10.1152/ajpendo.00107.2025. Epub 2025 Apr 28.
3
The Extract of Camellia Seed Cake Alleviates Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Mice by Promoting Coenzyme Q Synthesis.

本文引用的文献

1
The Mitochondrial Trigger in an Animal Model of Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病动物模型中的线粒体触发。
Genes (Basel). 2021 Sep 18;12(9):1439. doi: 10.3390/genes12091439.
2
3,5-Diiodo-L-Thyronine (T2) Administration Affects Visceral Adipose Tissue Inflammatory State in Rats Receiving Long-Lasting High-Fat Diet.3,5-二碘-L-甲状腺素(T2)给药对长期高脂肪饮食大鼠内脏脂肪组织炎症状态的影响。
Front Endocrinol (Lausanne). 2021 Jul 12;12:703170. doi: 10.3389/fendo.2021.703170. eCollection 2021.
3
The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies.
茶籽饼提取物通过促进辅酶Q合成减轻小鼠代谢功能障碍相关脂肪性肝病(MASLD)
Nutrients. 2025 Mar 15;17(6):1032. doi: 10.3390/nu17061032.
4
Mitochondria at the Crossroads: Linking the Mediterranean Diet to Metabolic Health and Non-Pharmacological Approaches to NAFLD.线粒体处于十字路口:将地中海饮食与代谢健康及非酒精性脂肪性肝病的非药物治疗方法联系起来。
Nutrients. 2025 Mar 30;17(7):1214. doi: 10.3390/nu17071214.
5
Dapansutrile Regulates Mitochondrial Oxidative Stress and Reduces Hepatic Lipid Accumulation in Diabetic Mice.达泮苏曲尔调节糖尿病小鼠的线粒体氧化应激并减少肝脏脂质积累。
Curr Issues Mol Biol. 2025 Feb 25;47(3):148. doi: 10.3390/cimb47030148.
6
The Role of Mitochondrial Quality Control in Liver Diseases: Dawn of a Therapeutic Era.线粒体质量控制在肝脏疾病中的作用:治疗时代的曙光
Int J Biol Sci. 2025 Feb 10;21(4):1767-1783. doi: 10.7150/ijbs.107777. eCollection 2025.
7
Associations between intake of different types of vegetables and metabolic dysfunction-associated fatty liver disease: a population-based study.不同类型蔬菜摄入量与代谢功能障碍相关脂肪性肝病之间的关联:一项基于人群的研究。
BMC Public Health. 2025 Jan 24;25(1):315. doi: 10.1186/s12889-025-21331-4.
8
Attenuates High-Fat-Diet-Induced Obesity and Especially Glucose Intolerance.可减轻高脂饮食诱导的肥胖,尤其可改善葡萄糖不耐受。
Nutrients. 2024 Nov 4;16(21):3780. doi: 10.3390/nu16213780.
9
Comparative effects of 3,5-diiodo-L-thyronine and 3,5,3'-triiodo-L-thyronine on mitochondrial damage and cGAS/STING-driven inflammation in liver of hypothyroid rats.3,5-二碘-L-甲状腺素和 3,5,3'-三碘-L-甲状腺素对甲状腺功能减退症大鼠肝脏线粒体损伤和 cGAS/STING 驱动的炎症的比较作用。
Front Endocrinol (Lausanne). 2024 Sep 5;15:1432819. doi: 10.3389/fendo.2024.1432819. eCollection 2024.
10
Melatonin Alleviates Liver Mitochondrial Dysfunction in Leptin-Deficient Mice.褪黑素可减轻瘦素缺乏小鼠的肝脏线粒体功能障碍。
Int J Mol Sci. 2024 Aug 8;25(16):8677. doi: 10.3390/ijms25168677.
重新审视活性氧(ROS)的化学性质:概述其在生物大分子(DNA、脂质和蛋白质)中的作用以及诱导的病理学。
Int J Mol Sci. 2021 Apr 28;22(9):4642. doi: 10.3390/ijms22094642.
4
Role of Insulin Resistance in MAFLD.胰岛素抵抗在 MAFLD 中的作用。
Int J Mol Sci. 2021 Apr 16;22(8):4156. doi: 10.3390/ijms22084156.
5
Therapeutic potential of mitochondrial uncouplers for the treatment of metabolic associated fatty liver disease and NASH.线粒体解偶联剂在治疗代谢相关脂肪性肝病和 NASH 中的治疗潜力。
Mol Metab. 2021 Apr;46:101178. doi: 10.1016/j.molmet.2021.101178. Epub 2021 Feb 3.
6
Role of mitochondria in liver metabolic health and diseases.线粒体在肝脏代谢健康和疾病中的作用。
Cell Calcium. 2021 Mar;94:102336. doi: 10.1016/j.ceca.2020.102336. Epub 2020 Dec 25.
7
Mitochondrial DNA copy number in human disease: the more the better?线粒体 DNA 拷贝数与人类疾病:多多益善?
FEBS Lett. 2021 Apr;595(8):976-1002. doi: 10.1002/1873-3468.14021. Epub 2020 Dec 25.
8
Reply to: correspondence regarding "A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement": Bringing evidence to the NAFLD-MAFLD debate.回复:关于“代谢功能障碍相关脂肪性肝病的新定义:一项国际专家共识声明”的通信:为非酒精性脂肪性肝病-代谢功能障碍相关脂肪性肝病的争论提供证据
J Hepatol. 2020 Dec;73(6):1575. doi: 10.1016/j.jhep.2020.07.045. Epub 2020 Sep 12.
9
From NAFLD to MAFLD: a "redefining" moment for fatty liver disease.从非酒精性脂肪性肝病到代谢相关脂肪性肝病:脂肪性肝病的一个“重新定义”时刻。
Chin Med J (Engl). 2020 Oct 5;133(19):2271-2273. doi: 10.1097/CM9.0000000000000981.
10
Liver-specific Prkn knockout mice are more susceptible to diet-induced hepatic steatosis and insulin resistance.肝特异性 Prkn 敲除小鼠更容易发生饮食诱导的肝脂肪变性和胰岛素抵抗。
Mol Metab. 2020 Nov;41:101051. doi: 10.1016/j.molmet.2020.101051. Epub 2020 Jul 10.